C-MER Medical Holdings (03309) Releases January 2026 Monthly Return on Movements in Securities

Bulletin Express02-02

C-MER Medical Holdings (03309) reported that its authorized share capital remained at 8,000,000,000 ordinary shares at a par value of HKD 0.1 each, totaling HKD 800,000,000. There was no change in the number of shares issued or held in treasury, with 1,212,780,870 issued shares (excluding treasury shares) and 19,562,000 treasury shares as of January 31, 2026.

The company confirmed that it continued to meet the required public float threshold of 25%. In addition, under its Post-IPO Share Option Scheme (exercise price at HKD 7.73), 133,334 share options remained outstanding at the end of January, with a total of 92,120,000 shares potentially issuable upon the full exercise of all share options. The filing also provided standard confirmations of compliance with listing rules and relevant regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment